Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

FDA Office of Criminal Investigations Automated Investigative Management System (AIMS) Modernization

Solicitation Number: RFI-FY14-OCIAIMS
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Location: Office of Acquisitions and Grants Services
  • Print

Note:

There have been modifications to this notice. You are currently viewing the original synopsis. To view the most recent modification/amendment, click here
:
RFI-FY14-OCIAIMS
:
Special Notice
:
Added: Apr 16, 2014 4:38 pm

Food and Drug Administration (FDA)
Office of Criminal Investigations (OCI)
Automated Investigative Management System (AIMS) Modernization


Request for Information (RFI)


This Request for Information (RFI) is being issued in accordance with Federal Acquisition Regulation Part 10, Market Research. It is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration or its Centers. Acknowledgment of receipt of responses will not be made, nor will respondents be notified of the outcome of the FDA's review of the information received. Responses to this announcement will not be returned, nor does the FDA intend to hold discussions concerning this RFI with any interested parties. However, FDA reserves the right to contact one or more of the respondents if additional information is required or to request demonstrations of available systems. This request is not to be construed as a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this request. This announcement may result in revisions in both its requirements and its acquisition strategy based on industry responses. Respondents must email its response to Danielle Pena at danielle.pena@fda.hhs.gov no later than 12:00 pm, Thursday, April 2, 2014.


The OCI requires a state of the art electronic system to preserve the collection and management of criminal investigative case information and administrative functions. The availability of timely access to current and historical data for analysis and forecasting trends involving FDA regulated products that threaten public health is critical to the mission. OCI intends to procure a web-based system that helps them to protect the public by providing a fully electronic system to preserve the collection and management of criminal investigative case information and administrative functions, automating business processes and workflows, enhanced reporting and searching capabilities, and enabling improved decision making and trend analyses.. The FDA is soliciting feedback on the clarity and completeness of its requirement in addition to identifying sources available to satisfy this requirement. Qualified small businesses (including Small Business Administration Certified 8(a) Companies; firms in Historically Underutilized Business Zones (HUBZone); Service-disabled veteran owned small businesses (SDVOSB); and Women-Owned small businesses (WOSB)) are highly encourage to submit a response.


General Instructions:


Responses to this RFI should not exceed 15 pages in length and shall include answers to all of the questions below. Please note a respondent's failure to provide a complete response to questions 1-4 will be interpreted to mean that it does not understand the question and does not demonstrate the capability to provide services required. Responses should demonstrate capability, not merely affirm the respondent's capability (e.g. The response must go beyond the statement that, "XYZ company can provide O&M support.").


Questions:


1. Provide a detailed narrative of at least two past performance examples with Government agencies and / or private industry within the past three years of similar size and scope detailed within the draft statement of work (SOW). The narrative should also include what COTS software was used and what parts were configurable by the end user/client; what platform/technology did the system operate on; did the system support workflow processes; did the system support case management, reporting and evidence tracking with barcoding capabilities; and did the system have a security and permissions model.


2. Provide a detailed narrative describing experience in completing the systems security accreditation for another Government agency. If your firm has experience with a law enforcement agency, please detail.

3. Provide a detailed narrative describing experience in creating a system that supports Personal Identification Verification (PIV).


4. Provide a detailed narrative describing experience in meeting customer requirements by configuration and customization of a COTS based system.


5. Provide documentation of your business if you are classified as a small business, HUBZone, SDVOSB, WOSB, and/or SBA 8(a) certified small business.


6. Provide the following:


a. Organization Name
b. DUNS Number
c. CAGE Code
d. Organization's website
e. Contact Name
f. Contact Telephone Number
g. Contact Email Address
h. Size Designation
i. Number of employees in your organization


7. Provide information concerning contract vehicles available to be used by the FDA in acquiring the software and services outlined in the draft SOW (GSA Federal Supply Schedules, Government Wide Acquisition Contracts, etc.).


8. What supporting documentation and /or additional information do you require to be released with the solicitation to obtain a better understanding of the FDA's requirement?


Attachment - Draft SOW 

Please consult the list of document viewers if you cannot open a file.

OCI AIMS DRAFT SOW

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
OCI AIMS DRAFT SOW
Posted Date:
April 16, 2014
Description: FDA OCI AIMS draft SOW
:
5630 Fishers Lane, Room 2129
Rockville, Maryland 20857-0001
:
Danielle Pena
Phone: 240-402-7548